Cartesian Therapeutics, Inc. — Director's Dealing 2019

Mar 29, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SELECTA BIOSCIENCES INC (SELB)
CIK: 0001453687
Period of Report: 2017-11-10

Reporting Person: SPRINGER TIMOTHY A (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-11-10	Common Stock	P	4752	$9.029	Acquired	9752	Indirect
2019-01-25	Common Stock	P	4000000	$1.50	Acquired	4456597	Direct
2019-01-25	Common Stock	P	66666	$1.50	Acquired	76418	Indirect

Footnotes

F1: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $8.83 to $9.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

F2: Reflects a correction to the Reporting Person's end of period holdings to reflect that 4,752 shares previously shown as held directly are held indirectly by the reporting person's wife.